Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


18.04.2017

3 AJR Am J Roentgenol
1 Am J Clin Pathol
1 Am J Epidemiol
1 Am J Surg
4 Anticancer Res
4 BMC Cancer
1 Br J Cancer
1 Breast Cancer
2 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
5 Breast Cancer Res Treat
2 Breast J
2 Cancer
1 Cancer Chemother Pharmacol
2 Cancer Res
1 Clin Breast Cancer
1 Eur J Cancer
1 Eur J Surg Oncol
1 Genes Chromosomes Cancer
1 Int J Oncol
3 J Clin Oncol
2 J Surg Oncol
1 Oncogene
3 Oncol Rep
4 PLoS One
2 Radiother Oncol
2 Semin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PLAZA MJ, Handa P, Esserman LE
    Preoperative MRI Evaluation of Axillary Lymph Nodes in Invasive Ductal Carcinoma: Comparison of Luminal A Versus Luminal B Subtypes in a Paradigm Using Ki-67 and Receptor Status.
    AJR Am J Roentgenol. 2017 Jan 31:1-5. doi: 10.2214/AJR.15.15788.
    PubMed     Text format     Abstract available

  2. HUANG ML, Speer M, Dogan BE, Rauch GM, et al
    Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up.
    AJR Am J Roentgenol. 2017 Jan 31:1-7. doi: 10.2214/AJR.16.16576.
    PubMed     Text format     Abstract available

  3. LEE J, Tanaka E, Eby PR, Zhou S, et al
    Preoperative Breast MRI: Surgeons' Patient Selection Patterns and Potential Bias in Outcomes Analyses.
    AJR Am J Roentgenol. 2016 Dec 27:1-10. doi: 10.2214/AJR.16.17038.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  4. BHARGAVA R, Florea AV, Pelmus M, Jones MW, et al
    Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.
    Am J Clin Pathol. 2017;147:399-410.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  5. DITE GS, MacInnis RJ, Bickerstaffe A, Dowty JG, et al
    Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.
    Am J Epidemiol. 2017;185:487-500.
    PubMed     Text format     Abstract available


    Am J Surg

  6. MAYS S, Alabdulkareem H, Christos P, Simmons R, et al
    Surgical outcomes in women >/=70 years undergoing mastectomy with and without reconstruction for breast cancer.
    Am J Surg. 2017 Apr 5. pii: S0002-9610(16)30981.
    PubMed     Text format     Abstract available


    Anticancer Res

  7. IIZUKA D, Sasatani M, Barcellos-Hoff MH, Kamiya K, et al
    Hydrogen Peroxide Enhances TGFbeta-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells.
    Anticancer Res. 2017;37:987-995.
    PubMed     Text format     Abstract available

  8. SEKIDO Y, Ohigashi S, Takahashi T, Hayashi N, et al
    Familial Gastrointestinal Stromal Tumor with Germline KIT Mutations Accompanying Hereditary Breast and Ovarian Cancer Syndrome.
    Anticancer Res. 2017;37:1425-1431.
    PubMed     Text format     Abstract available

  9. WINDRICHOVA J, Fuchsova R, Kucera R, Topolcan O, et al
    MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Anticancer Res. 2017;37:1501-1505.
    PubMed     Text format     Abstract available

  10. CHIRICO A, Serpentini S, Merluzzi T, Mallia L, et al
    Self-efficacy for Coping Moderates the Effects of Distress on Quality of Life in Palliative Cancer Care.
    Anticancer Res. 2017;37:1609-1615.
    PubMed     Text format     Abstract available


    BMC Cancer

  11. YANG X, Pei S, Wang H, Jin Y, et al
    Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
    BMC Cancer. 2017;17:255.
    PubMed     Text format     Abstract available

  12. SPITZWIESER M, Entfellner E, Werner B, Pulverer W, et al
    Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    BMC Cancer. 2017;17:260.
    PubMed     Text format     Abstract available

  13. VAN DEN BERG MM, Winkels RM, de Kruif JT, van Laarhoven HW, et al
    Weight change during chemotherapy in breast cancer patients: a meta-analysis.
    BMC Cancer. 2017;17:259.
    PubMed     Text format     Abstract available

  14. PESTALOZZI BC, Tausch C, Dedes KJ, Rochlitz C, et al
    Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
    BMC Cancer. 2017;17:265.
    PubMed     Text format     Abstract available


    Br J Cancer

  15. MILLER AB
    Comment on 'Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study'.
    Br J Cancer. 2017 Apr 11. doi: 10.1038/bjc.2017.
    PubMed     Text format    


    Breast Cancer

  16. HANAMURA T, Hayashi SI
    Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
    Breast Cancer. 2017 Apr 7. doi: 10.1007/s12282-017-0772.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  17. YANG XL, Qi LG, Lin FJ, Ou ZL, et al
    The role of the chemokine receptor XCR1 in breast cancer cells.
    Breast Cancer (Dove Med Press). 2017;9:227-236.
    PubMed     Text format     Abstract available

  18. MORTON R, Sayma M, Sura MS
    Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?
    Breast Cancer (Dove Med Press). 2017;9:217-225.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  19. TOI M, Shao Z, Hurvitz S, Tseng LM, et al
    Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.
    Breast Cancer Res. 2017;19:47.
    PubMed     Text format     Abstract available

  20. CORDONE I, Masi S, Summa V, Carosi M, et al
    Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
    Breast Cancer Res. 2017;19:46.
    PubMed     Text format     Abstract available

  21. PAQUET ER, Lesurf R, Tofigh A, Dumeaux V, et al
    Erratum to: Detecting gene signature activation in breast cancer in an absolute, single-patient manner.
    Breast Cancer Res. 2017;19:48.
    PubMed     Text format    


    Breast Cancer Res Treat

  22. HAN J, Choi YL, Kim H, Choi JY, et al
    MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Breast Cancer Res Treat. 2017 Apr 13. doi: 10.1007/s10549-017-4234.
    PubMed     Text format     Abstract available

  23. BALLINGER TJ, Kassem N, Shen F, Jiang G, et al
    Discerning the clinical relevance of biomarkers in early stage breast cancer.
    Breast Cancer Res Treat. 2017 Apr 11. doi: 10.1007/s10549-017-4238.
    PubMed     Text format     Abstract available

  24. KUCHARCZYK MJ, Parpia S, Walker-Dilks C, Banfield L, et al
    Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.
    Breast Cancer Res Treat. 2017 Apr 11. doi: 10.1007/s10549-017-4228.
    PubMed     Text format     Abstract available

  25. GRANT WB
    Racial disparity in vitamin D status may explain racial disparity in survival from estrogen and progesterone receptor-positive breast cancer.
    Breast Cancer Res Treat. 2017 Apr 10. doi: 10.1007/s10549-017-4237.
    PubMed     Text format    

  26. ZHANG X, Brown JC, Paskett ED, Zemel BS, et al
    Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema.
    Breast Cancer Res Treat. 2017 Apr 8. doi: 10.1007/s10549-017-4221.
    PubMed     Text format     Abstract available


    Breast J

  27. ASSING MA, Patel BK, Karamsadkar N, Weinfurtner J, et al
    A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer.
    Breast J. 2017 Apr 10. doi: 10.1111/tbj.12812.
    PubMed     Text format     Abstract available

  28. LI M, Xu B, Shao Y, Liu H, et al
    Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors.
    Breast J. 2017 Apr 10. doi: 10.1111/tbj.12811.
    PubMed     Text format     Abstract available


    Cancer

  29. GUCALP A, Traina TA
    Androgen receptor-positive, triple-negative breast cancer.
    Cancer. 2017 Apr 12. doi: 10.1002/cncr.30683.
    PubMed     Text format    

  30. KATZ SJ, Wallner LP, Abrahamse PH, Janz NK, et al
    Treatment experiences of Latinas after diagnosis of breast cancer.
    Cancer. 2017 Apr 11. doi: 10.1002/cncr.30702.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  31. REN YQ, Wang HJ, Zhang YQ, Liu YB, et al
    WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206.
    Cancer Chemother Pharmacol. 2017 Apr 8. doi: 10.1007/s00280-017-3302.
    PubMed     Text format     Abstract available


    Cancer Res

  32. HANKER AB, Estrada MV, Bianchini G, Moore PD, et al
    Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer.
    Cancer Res. 2017 Apr 10. pii: canres.2808.2016.
    PubMed     Text format     Abstract available

  33. GAGGIANESI M, Turdo A, Chinnici A, Lipari E, et al
    IL-4 primes the dynamics of breast cancer progression via DUSP4 inhibition.
    Cancer Res. 2017 Apr 11. pii: canres.3126.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  34. WADASADAWALA T, Vadgaonkar R, Bajpai J
    Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
    Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(16)30416.
    PubMed     Text format     Abstract available


    Eur J Cancer

  35. KOSMIN M, Makris A, Joshi PV, Ah-See ML, et al
    The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.
    Eur J Cancer. 2017;77:109-116.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  36. PUKANCSIK D, Kelemen P, Ujhelyi M, Kovacs E, et al
    Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study.
    Eur J Surg Oncol. 2017;43:303-310.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  37. SUN H, Liu T, Zhu D, Dong X, et al
    HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
    Genes Chromosomes Cancer. 2017 Apr 10. doi: 10.1002/gcc.22463.
    PubMed     Text format     Abstract available


    Int J Oncol

  38. DING Y, Zhang C, Zhang J, Zhang N, et al
    miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression.
    Int J Oncol. 2017;50:1701-1710.
    PubMed     Text format     Abstract available


    J Clin Oncol

  39. AHN S, Port ER
    Genetic Testing in Patients With Newly Diagnosed Breast Cancer: Room for Improvement.
    J Clin Oncol. 2017 Apr 14:JCO2017728816. doi: 10.1200/JCO.2017.72.8816.
    PubMed     Text format    

  40. BLUM JL, Flynn PJ, Yothers G, Asmar L, et al
    Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
    J Clin Oncol. 2017 Apr 11:JCO2016714147. doi: 10.1200/JCO.2016.71.4147.
    PubMed     Text format     Abstract available

  41. KURIAN AW, Li Y, Hamilton AS, Ward KC, et al
    Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
    J Clin Oncol. 2017 Apr 12:JCO2016716480. doi: 10.1200/JCO.2016.71.6480.
    PubMed     Text format     Abstract available


    J Surg Oncol

  42. TSENG J, Kyrillos A, Liederbach E, Spear GG, et al
    Clinical accuracy of preoperative breast MRI for breast cancer.
    J Surg Oncol. 2017 Apr 13. doi: 10.1002/jso.24616.
    PubMed     Text format     Abstract available

  43. BEAR HD, Wan W, Robidoux A, Rubin P, et al
    Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
    J Surg Oncol. 2017 Apr 13. doi: 10.1002/jso.24610.
    PubMed     Text format     Abstract available


    Oncogene

  44. CHEN Y, Zeng C, Zhan Y, Wang H, et al
    Aberrant low expression of p85alpha in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  45. DIMAS-GONZALEZ J, Maldonado-Lagunas V, Diaz-Chavez J, Lopez-Arellano ME, et al
    Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer.
    Oncol Rep. 2017;37:3026-3036.
    PubMed     Text format     Abstract available

  46. HE J, Mai J, Li Y, Chen L, et al
    miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.
    Oncol Rep. 2017;37:2672-2678.
    PubMed     Text format     Abstract available

  47. NANASHIMA N, Horie K, Yamada T, Shimizu T, et al
    Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness.
    Oncol Rep. 2017;37:2964-2970.
    PubMed     Text format     Abstract available


    PLoS One

  48. GUO Y, Yu P, Liu Z, Maimaiti Y, et al
    Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0174843.
    PubMed     Text format     Abstract available


  49. Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells.
    PLoS One. 2017;12:e0175772.
    PubMed     Text format    


  50. Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.
    PLoS One. 2017;12:e0175869.
    PubMed     Text format    

  51. KIM MS, Kim SY, Kim JH, Park B, et al
    Depression in breast cancer patients who have undergone mastectomy: A national cohort study.
    PLoS One. 2017;12:e0175395.
    PubMed     Text format     Abstract available


    Radiother Oncol

  52. BEST L, de Metz C, Olivotto IA, Roy I, et al
    Radiation therapy quality indicators for invasive breast cancer.
    Radiother Oncol. 2017 Apr 10. pii: S0167-8140(17)30133.
    PubMed     Text format     Abstract available

  53. CHESNEY TR, Yin JX, Rajaee N, Tricco AC, et al
    Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis.
    Radiother Oncol. 2017;123:1-9.
    PubMed     Text format     Abstract available


    Semin Oncol

  54. PEAIRS KS, Choi Y, Stewart RW, Sateia HF, et al
    Screening for breast cancer.
    Semin Oncol. 2017;44:60-72.
    PubMed     Text format     Abstract available

  55. MARCUS PM, Durham DD
    Commentary on "Screening for breast cancer" by Peairs et al.
    Semin Oncol. 2017;44:73.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: